About Sera Prognostics
Sera Prognostics is a company based in Salt Lake City (United States) founded in 2008. It operates as a HealthTech. The company has 123 employees as of December 31, 2021. Sera Prognostics offers products and services including PreTRM Test and LikeMine Platform. Sera Prognostics operates in a competitive market with competitors including Mirvie, Pregnolia, Yourgene Health, NX Prenatal and Rea Diagnostics, among others.
- Headquarter Salt Lake City, United States
- Employees 123 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sera Prognostics
-
Annual Revenue
$268 K0as on Dec 31, 2022
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
123
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sera Prognostics
Sera Prognostics is a publicly listed company on the NASDAQ with ticker symbol SERA in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Sera Prognostics
Sera Prognostics offers a comprehensive portfolio of products and services, including PreTRM Test and LikeMine Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Risk of preterm delivery is predicted through blood test.
Pregnancy outcomes are compared using extensive U.S. data.
Unlock access to complete
Funding Insights of Sera Prognostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Sera Prognostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sera Prognostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sera Prognostics Comparisons
Competitors of Sera Prognostics
Sera Prognostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mirvie, Pregnolia, Yourgene Health, NX Prenatal and Rea Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
|
| domain | founded_year | HQ Location |
Preterm birth risks are predicted using cervical stiffness measurement devices.
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genetic tests and genomic services are provided.
|
|
| domain | founded_year | HQ Location |
Early warning blood tests for pregnancy complications are provided.
|
|
| domain | founded_year | HQ Location |
Wearable diagnostic device is provided to monitor preterm birth risks.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sera Prognostics
Frequently Asked Questions about Sera Prognostics
When was Sera Prognostics founded?
Sera Prognostics was founded in 2008.
Where is Sera Prognostics located?
Sera Prognostics is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
How many employees does Sera Prognostics have?
As of Dec 31, 2021, the latest employee count at Sera Prognostics is 123.
What is the annual revenue of Sera Prognostics?
Annual revenue of Sera Prognostics is $268K as on Dec 31, 2022.
What does Sera Prognostics do?
Sera Prognostics is dedicated to advancing womens health diagnostics with a focus on prenatal care. Solutions are developed to predict risks such as preterm delivery for pregnant women. The company serves healthcare providers, payers, employers, and mothers through innovative tools like the PreTRM Test and LikeMine platform. Research and innovation in maternal biomarkers are emphasized to improve neonatal outcomes and reduce healthcare costs. The healthcare sector, specifically prenatal testing, is the primary area of operation.
Who are the top competitors of Sera Prognostics?
Sera Prognostics's top competitors include Mirvie, NX Prenatal and Yourgene Health.
What products or services does Sera Prognostics offer?
Sera Prognostics offers PreTRM Test and LikeMine Platform.
Is Sera Prognostics publicly traded?
Yes, Sera Prognostics is publicly traded on NASDAQ under the ticker symbol SERA.
What is Sera Prognostics's ticker symbol?
The ticker symbol of Sera Prognostics is SERA on NASDAQ.